Medical Devices Series A Investors & VC Firms

1128 firms in this list, with a median first check of $500K. 245 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
NO Novalis LifeSciences MDDLPMCG9 people	88🔒	Portsmouth	US	Seed–Late Stage	—	+ Add to CRM
LE Leading Edge Ventures MBDPJDRB5 people	88🔒	Newark	US	Seed–Series A	$50K – $750K	+ Add to CRM
SU Sugati Ventures RDEGMCEH8 people · Leads rounds	88🔒	San Ramon	US	Seed–Series A	—	+ Add to CRM
DE Device of Tomorrow Capital HYDO2 people	88🔒	—		Seed–Growth	—	+ Add to CRM
BI BioTrack Capital FTKCLLJG7 people	88🔒	Shanghai	CN	Pre-Seed–Series A	—	+ Add to CRM
BL BlueStone Venture Partners MATNCBAM4 people	88🔒	Tucson	US	Seed–Series B	$250K – $1M	+ Add to CRM
MA Magnivia Ventures PSKAPMSH7 people	88🔒	New Jersey	US	Pre-Seed–Series B	$250K – $750K	+ Add to CRM
SN Snatched Ventures KCAZ2 people · Follows rounds	88🔒	San Francisco	US	Seed–Series A	—	+ Add to CRM
BI Birch Venture Capital, Inc. MWLLTH3 people	88🔒	Taipei City	TW	Seed–Late Stage	—	+ Add to CRM
BL BlueOcean Ventures EDFSSHTZ6 people · Leads rounds	88🔒	Geneva	CH	Seed–Series A	$270K – $1.4M	+ Add to CRM
HE HealthXCapital AMSJSGDK6 people · Leads rounds	88🔒	Singapore	SG	Pre-Seed–Series A	—	+ Add to CRM
AZ AZ Venture Capital Inc. JGSRJPJN5 people · Follows rounds	88🔒	Phoenix	US	Pre-Seed–Series A	—	+ Add to CRM
CA CARMA FUND CLMRCSMM5 people	88🔒	Munich	DE	Pre-Seed–Series A	—	+ Add to CRM
KE Kern Capital, LLC JK1 person · Leads rounds	88🔒	Larkspur	US	Series A–Late Stage	$5M – $15M	+ Add to CRM
AR Artem Ventures LZNSTOGK4 people	88🔒	Kuala Lumpur	MY	Pre-Seed–Series A	—	+ Add to CRM
GL Global BioAccess Fund BRLWTMSG7 people	88🔒	New York	US	Series A–Late Stage	$10M	+ Add to CRM
IN Innosphere Ventures MFMNMRJS4 people · Leads rounds	88🔒	Boulder	US	Seed–Series A	—	+ Add to CRM
RO Rockies Venture Adviser, Llc CSDHKKKM7 people · Leads rounds	88🔒	Denver	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
SA Salvia HJCJFAIM4 people	88🔒	Holzkirchen	DE	Seed–Series B	—	+ Add to CRM
TI TiVenture SA PODMRGSM4 people · Leads rounds	88🔒	Lugano	CH	Pre-Seed–Series B	—	+ Add to CRM
MA Marram Ventures MFSLGL3 people	88🔒	Saugatuck	US	Seed–Series B	$3M	+ Add to CRM
AR Arkitekt Ventures EB1 person · Follows rounds	88🔒	New York	US	Seed–Series A	$100K – $10M	+ Add to CRM
CU Curie Capital HDMVOTHV8 people · Leads rounds	88🔒	Amsterdam	NL	Seed–Series A	—	+ Add to CRM
DO DoubleRock NDSR2 people	88🔒	San Francisco	US	Seed–Series A	$2M – $15M	+ Add to CRM

Novalis LifeSciences

PortsmouthSeed–Late Stage

MDDLPMCG9 people

Leading Edge Ventures

NewarkSeed–Series A$50K – $750K

MBDPJDRB5 people

Sugati Ventures

San RamonSeed–Series A

RDEGMCEH8 people

Device of Tomorrow Capital

Seed–Growth

HYDO2 people

BioTrack Capital

ShanghaiPre-Seed–Series A

FTKCLLJG7 people

BlueStone Venture Partners

TucsonSeed–Series B$250K – $1M

MATNCBAM4 people

Magnivia Ventures

New JerseyPre-Seed–Series B$250K – $750K

PSKAPMSH7 people

Snatched Ventures

San FranciscoSeed–Series A

KCAZ2 people

Birch Venture Capital, Inc.

Taipei CitySeed–Late Stage

MWLLTH3 people

BlueOcean Ventures

GenevaSeed–Series A$270K – $1.4M

EDFSSHTZ6 people

HealthXCapital

SingaporePre-Seed–Series A

AMSJSGDK6 people

AZ Venture Capital Inc.

PhoenixPre-Seed–Series A

JGSRJPJN5 people

CARMA FUND

MunichPre-Seed–Series A

CLMRCSMM5 people

Kern Capital, LLC

LarkspurSeries A–Late Stage$5M – $15M

JK1 person

Artem Ventures

Kuala LumpurPre-Seed–Series A

LZNSTOGK4 people

Global BioAccess Fund

New YorkSeries A–Late Stage$10M

BRLWTMSG7 people

Innosphere Ventures

BoulderSeed–Series A

MFMNMRJS4 people

Rockies Venture Adviser, Llc

DenverPre-Seed–Series A$100K – $500K

CSDHKKKM7 people

Salvia

HolzkirchenSeed–Series B

HJCJFAIM4 people

TiVenture SA

LuganoPre-Seed–Series B

PODMRGSM4 people

Marram Ventures

SaugatuckSeed–Series B$3M

MFSLGL3 people

Arkitekt Ventures

New YorkSeed–Series A$100K – $10M

EB1 person

Curie Capital

AmsterdamSeed–Series A

HDMVOTHV8 people

DoubleRock

San FranciscoSeed–Series A$2M – $15M

NDSR2 people

Data sourced from public filings and firms' own websites — see our methodology.